Physician profile
Charles E Crouse
NPI 1518131549
$1,192.16
in general payments reported to CMS, 2019-2025
18 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.84 · 2020: $42.77 · 2021: $466 · 2022: $46.91 · 2023: $60.91 · 2024: $135 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $480.48 | 2021-2025 | Juggerknotless Soft Anchor |
| Depuy Synthes Sales INC. | $121.31 | 2019-2025 | Monovisc, Orthovisc |
| Medical Device Business Services, INC. | $120.00 | 2025 | Actis |
| Orthofix Medical, INC. | $70.98 | 2021-2024 | Physio-Stim |
| Ferring Pharmaceuticals INC. | $66.98 | 2019-2023 | Euflexxa |
| Endo Pharmaceuticals INC. | $53.07 | 2019-2021 | |
| Pacira Therapeutics, INC. | $40.93 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $34.29 | 2022-2025 | Exparel |
| Organogenesis INC. | $29.23 | 2021 | |
| Davol INC. | $24.99 | 2025 | Arista |
| Fidia Pharma USA INC. | $23.28 | 2024 | Hymovis |
| Deroyal Industries, INC. | $21.12 | 2019-2020 | |
| Stryker Corporation | $20.81 | 2024 | Mako |
| Djo, LLC | $20.29 | 2019 | |
| Solventum Corporation | $18.62 | 2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $16.03 | 2024 | Sprint Pns System |
| Legacy Ortho LLC | $15.67 | 2023 | |
| Horizon Therapeutics Plc | $14.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Crouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.